Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00539162 · ClinicalTrials.gov registry record · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
A NA study of Ovarian Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 8,000
- Enrollment target
- 11
- Study locations
NCT00539162: Recruiting NA study of Ovarian Cancer, sponsored by M.D. Anderson Cancer Center.
NCT00539162 is a NA study of Ovarian Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 8,000 participants, above the 704-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (1036% higher). The trial reports 11 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00539162, a NA study of Ovarian Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 8,000 participants
- Enrollment target
- 11
- Study locations
Study Summary
The goal of this clinical research study is to evaluate a method involving 4 blood tests called CA-125, HE4, HE4 antigen autoantibody complexes, and osteopontin that may be helpful in the early detection of ovarian cancer in women who are at low risk.
Primary Outcome
\[Time Frame: Based on CA-125 level and other tumor markers, 3 options will result: 1) re-draw blood (CA-125 and other tumor markers) in 1 year, 2) re-draw blood (CA-125 and other tumor markers) in 3 months, or 3) re-draw blood (CA-125 and other tumor markers) and TVUS in 6 weeks +/- 2 weeks.\]
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
Study Locations (11)
Texas
- The University of Texas at Austin - Austin
- University of Texas (UT) Southwestern Medical Center - Dallas
- University of Texas MD Anderson Cancer Center - Houston
- Women's Hospital of Texas, Obstetrics and Gynecology Associates (OGA) - Houston
- UT Health Science Center San Antonio - San Antonio
Florida
- Sylvester Comprehensive Cancer Center, Univ of Miami Miller School of Medicine - Miami
Iowa
- John Stoddard Cancer Center - Des Moines
New Jersey
- Carol G. Simon Cancer Center / Atlantic Health - Morristown
New York
- University of Rochester Medical Center - Rochester
Oklahoma
- University of Oklahoma Health Sciences Center - Oklahoma City
Rhode Island
- Women's and Infant's Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,000 participants |
| Start Date | 2001-07-02 |
| Est. Completion | 2028-11-30 |
| Phase | NA |
What NCT00539162 shows while recruiting
NCT00539162 is an interventional study that assigns participants to a tested intervention. Its 8,000 participants enrollment target places it among the larger protocols in the corpus, above the 704-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (1036% higher).
The record links to 1 condition, with Ovarian Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.
NCT00539162 lists 11 locations in 7 states (Texas, Florida, Iowa).
Frequently Asked Questions
What is clinical trial NCT00539162 about?
NCT00539162 is a clinical study titled "Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women". The goal of this clinical research study is to evaluate a method involving 4 blood tests called CA-125, HE4, HE4 antigen autoantibody complexes, and osteopontin that may be helpful in the early detection of ovarian cancer in women who are at low risk.
What is the current status of trial NCT00539162?
This trial is currently recruiting. It is a NA study. The enrollment target is 8,000 participants. The study started on 2001-07-02. Estimated completion is 2028-11-30.
What conditions does trial NCT00539162 study?
This clinical trial studies the following conditions: Ovarian Cancer.
What interventions are being tested in trial NCT00539162?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00539162?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00539162 being conducted?
This trial has 11 study locations across Florida, Iowa, New Jersey, New York, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00539162's enrollment target sits among peer trials
8,000 7th of 322 higher than 316 of 322 other Ovarian Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ovarian Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
RECRUITING · NA
-
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
RECRUITING · NA
-
Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
- NCT03072927 · 8,000 participants
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
- NCT04075305 · 8,000 participants
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI